Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07795502.9Aexternal-prioritypatent/EP2044101B1/en
Application filed by Novartis AgfiledCriticalNovartis Ag
Publication of CY1114753T1publicationCriticalpatent/CY1114753T1/en
Η παρούσα αίτηση περιγράφει οργανικές ενώσεις οι οποίες είναι χρήσιμες στη θεραπευτική αντιμετώπιση, πρόληψη και/ή βελτίωση νόσων.This application describes organic compounds which are useful in the treatment, prevention and / or amelioration of diseases.
CY20141100020T2006-05-312014-01-09
Aminothiazole derivatives and their uses as antibacterial agents
CY1114753T1
(en)
Compounds derived from 2,7-naphthyridines-1-one, mediators of syk; pharmaceutical composition; and use in the treatment of inflammatory, respiratory, cellular proliferative or autoimmune disease.
MACROCICLICAL COMPOUNDS DERIVED FROM 6-ARIL-4-MERCAPTO- [1.3.5] TRIAZINA / [1.3] PIRIMIDIN-2-AMINA; PHARMACEUTICAL COMPOSITION, USEFUL IN THE TREATMENT OF CANCER.